Ivan Schindelholz

Title: Ivan Schindelholz: Innovator in Pharmaceutical Chemistry

Introduction

Ivan Schindelholz is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on the development of novel compounds and processes that have potential therapeutic applications.

Latest Patents

Among his latest patents is the invention concerning crystalline forms of a 4-pyrimidinesulfamide derivative, aprocitentan. This invention details novel crystalline forms of {5-(4-bromo-phenyl)-6-[2-(5-bromo-pyrimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl}-sulfamide, along with processes for their preparation. It also discusses pharmaceutical compositions that include these crystalline forms and their use as endothelin receptor antagonists. Another significant patent involves a process for manufacturing pyrimidine sulfamide derivatives, which outlines a method for synthesizing compounds with specific chemical structures.

Career Highlights

Ivan Schindelholz has worked with prominent companies in the pharmaceutical industry, including Actelion Pharmaceuticals Ltd and Idorsia Pharmaceuticals Ltd. His experience in these organizations has allowed him to contribute to innovative drug development and research.

Collaborations

Some of his notable coworkers include Stefan Abele and Jacques-Alexis Funel. Their collaborative efforts have likely enhanced the research and development processes within their respective projects.

Conclusion

Ivan Schindelholz is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to advancing medical science through the development of new therapeutic agents.